GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Healthcare AI Acquisition Corp (NAS:HAIA) » Definitions » Research & Development

Healthcare AI Acquisition (Healthcare AI Acquisition) Research & Development : $0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Healthcare AI Acquisition Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Healthcare AI Acquisition's Research & Development for the three months ended in Dec. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.

Healthcare AI Acquisition Research & Development Historical Data

The historical data trend for Healthcare AI Acquisition's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthcare AI Acquisition Research & Development Chart

Healthcare AI Acquisition Annual Data
Trend Dec21 Dec22 Dec23
Research & Development
- - -

Healthcare AI Acquisition Quarterly Data
Feb21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Healthcare AI Acquisition Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthcare AI Acquisition  (NAS:HAIA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Healthcare AI Acquisition Research & Development Related Terms

Thank you for viewing the detailed overview of Healthcare AI Acquisition's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Healthcare AI Acquisition (Healthcare AI Acquisition) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Healthcare AI Acquisition Corp (NAS:HAIA) » Definitions » Research & Development
Comparable Companies
YOTA NUBI SWSS CREEF AEAE GGAAF LIBY OAKU ARTE GTAC PBAJ SVMB SCRM CVII AAC GHIX ALCC AACT DWAC SAGA
Traded in Other Exchanges
N/A
Address
190 Elgin Avenue, George Town, Grand Cayman, CYM, KY1-9008
Website
Healthcare AI Acquisition Corp is a blank check company.
Executives
Polar Asset Management Partners Inc. 10 percent owner 16 YORK STREET SUITE 2900, TORONTO A6 M5J 0E6
Atticus Ale, Llc 10 percent owner 8 THE GREEN, SUITE 15614, DOVER DE 19901
Zikang Wu director, 10 percent owner, officer: Chief Executive Officer PO BOX 309, UGLAND HOUSE, GRAND CAYMAN E9 KY1-1104
Yuerong Tang director 8 THE GREEN, SUITE 15614, DOVER DE 19901
Hao Tian director 8 THE GREEN, SUITE 15614, DOVER DE 19901
Zixun Jin director 8 THE GREEN, SUITE 15614, DOVER DE 19901
Weiyi Zheng director 8 THE GREEN, SUITE 15614, DOVER DE 19901
Robert Piconi director C/O HEALTHCARE AI ACQUISITION, 7 STANLEY GARDENS, LONDON X0 W112ND
Elizabeth K Weymouth director 55 HUDSON YARDS, 44TH FLOOR, NEW YORK NY 10001
Xavier Flinois director
James William Brooks director 7 STANLEY GARDENS, LONDON X0 W112ND
Patrick Hargutt director, officer: Chief Financial Officer 7 STANLEY GARDENS, LONDON X0 W112ND
Simon Lyall-cottle director, officer: Chief Executive Officer 7 STANLEY GARDENS, LONDON X0 W112ND
Healthcare Ai Acquisition Llc 10 percent owner 7 STANLEY GARDENS, LONDON X0 W112ND
Greg Caswill director C/O HEALTHCARE AI ACQUISITION, 7 STANLEY GARDENS, LONDON X0 W112ND